LeMaitre Vascular Inc (LMAT) - Total Assets
Based on the latest financial reports, LeMaitre Vascular Inc (LMAT) holds total assets worth $598.07 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See LeMaitre Vascular Inc (LMAT) shareholders funds for net asset value and shareholders' equity analysis.
LeMaitre Vascular Inc - Total Assets Trend (2001–2024)
This chart illustrates how LeMaitre Vascular Inc's total assets have evolved over time, based on quarterly financial data.
LeMaitre Vascular Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
LeMaitre Vascular Inc's total assets of $598.07 Million consist of 72.9% current assets and 27.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.6% |
| Accounts Receivable | $30.06 Million | 5.5% |
| Inventory | $55.94 Million | 10.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $35.82 Million | 6.5% |
| Goodwill | $65.94 Million | 12.0% |
Asset Composition Trend (2001–2024)
This chart illustrates how LeMaitre Vascular Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see LeMaitre Vascular Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LeMaitre Vascular Inc's current assets represent 72.9% of total assets in 2024, an increase from 48.2% in 2001.
- Cash Position: Cash and equivalents constituted 4.6% of total assets in 2024, up from 0.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is goodwill at 12.0% of total assets.
LeMaitre Vascular Inc Competitors by Total Assets
Key competitors of LeMaitre Vascular Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
LeMaitre Vascular Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 13.58 | 7.74 | 3.75 |
| Quick Ratio | 11.45 | 5.79 | 2.19 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $418.74 Million | $197.77 Million | $69.12 Million |
LeMaitre Vascular Inc - Advanced Valuation Insights
This section examines the relationship between LeMaitre Vascular Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.18 |
| Latest Market Cap to Assets Ratio | 3.60 |
| Asset Growth Rate (YoY) | 59.1% |
| Total Assets | $551.82 Million |
| Market Capitalization | $1.99 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values LeMaitre Vascular Inc's assets at a significant premium (3.60x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: LeMaitre Vascular Inc's assets grew by 59.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for LeMaitre Vascular Inc (2001–2024)
The table below shows the annual total assets of LeMaitre Vascular Inc from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $551.82 Million | +59.13% |
| 2023-12-31 | $346.78 Million | +11.69% |
| 2022-12-31 | $310.48 Million | +6.04% |
| 2021-12-31 | $292.80 Million | +15.82% |
| 2020-12-31 | $252.81 Million | +34.23% |
| 2019-12-31 | $188.34 Million | +23.03% |
| 2018-12-31 | $153.09 Million | +21.19% |
| 2017-12-31 | $126.32 Million | +23.94% |
| 2016-12-31 | $101.92 Million | +12.37% |
| 2015-12-31 | $90.70 Million | +11.30% |
| 2014-12-31 | $81.49 Million | +15.60% |
| 2013-12-31 | $70.49 Million | +11.79% |
| 2012-12-31 | $63.06 Million | +5.65% |
| 2011-12-31 | $59.69 Million | -5.67% |
| 2010-12-31 | $63.27 Million | +11.19% |
| 2009-12-31 | $56.91 Million | +4.61% |
| 2008-12-31 | $54.40 Million | -11.04% |
| 2007-12-31 | $61.15 Million | +7.35% |
| 2006-12-31 | $56.96 Million | +127.23% |
| 2005-12-31 | $25.07 Million | +22.28% |
| 2004-12-31 | $20.50 Million | +61.20% |
| 2002-12-31 | $12.72 Million | +4.57% |
| 2001-12-31 | $12.16 Million | -- |
About LeMaitre Vascular Inc
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arte… Read more